Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STRN | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | UCN3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | C9orf84 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | AC213203.1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | LINC00694 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | PRAP1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | CPNE3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | CENPK | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | CD53 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | SF3A2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |